Condensed Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Cash flows from operating activities:
Net income (loss)	$ 186,735	$ (1,074,498)	$ (3,800,000)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	2,060	2,958
Stock-based compensation expense	51,119
Changes in assets and liabilities:
Prepaid expenses and other current assets	40,825	199,102
Other assets	6,228
Right-of-use asset	31,610	45,654
Accounts payable	(310,497)	150,347
Decrease in lease liabilities	(33,605)	(47,529)
Accrued expenses and other current liabilities	19,641	24,156
Net cash used in operating activities	(5,884)	(699,810)
Cash flows from financing activities
Preferred stock dividend		(68,809)
Net cash used in financing activities		(68,809)
Net decrease in cash and cash equivalents	(5,884)	(768,619)
Cash and cash equivalents at beginning of period	2,070,075	1,374,992	1,374,992
Cash and cash equivalents at end of period	2,064,191	606,373	$ 2,070,075
Supplemental disclosure of Cash Flow Information:
Conversion of Series C Preferred Stock to Common Stock		$ 2,011,351